ArticleClinical lymphoma, myeloma & leukemia2014

A phase I study of fludarabine, cytarabine, and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia.

Apostolia Maria Tsimberidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.